Imbalance between the anti‐ and pro‐inflammatory milieu in blood leukocytes of autistic children

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Molecular Immunology

• Publication date

  2017-02-01

• Fields of study

  Medicine, Psychology

• Identifiers
  DOI 10.1016/j.molimm.2016.12.019PMID 28027499
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• A Validated Regulatory Network for Th17 Cell Specification.

  2025cited by this paper
• Dysregulation of Th1, Th2, Th17, and T regulatory cell-related transcription factor signaling in children with autism

  2016cited by this paper
• Protection of TGF-β1 against Neuroinflammation and Neurodegeneration in Aβ1–42-Induced Alzheimer’s Disease Model Rats

  2015cited by this paper
• Whole-Exome Sequencing in a South American Cohort Links ALDH1A3, FOXN1 and Retinoic Acid Regulation Pathways to Autism Spectrum Disorders

  2015cited by this paper
• Interleukin-27 in T Cell Immunity

  2015cited by this paper
• The role of inflammatory cytokines as key modulators of neurogenesis.

  2015cited by this paper
• Histamine 4 receptor promotes expression of costimulatory B7.1/B7.2 molecules, CD28 signaling and cytokine production in stress-induced immune responses.

  2015cited by this paper
• Reduced frequency of T lymphocytes expressing CTLA-4 in frontotemporal dementia compared to Alzheimer's disease.

  2014cited by this paper
• Involvement of histamine 4 receptor in the pathogenesis and progression of rheumatoid arthritis.

  2014cited by this paper
• T cell–derived interleukin (IL)-21 promotes brain injury following stroke in mice

  2014cited by this paper
• Group I metabotropic glutamate receptor mediated dynamic immune dysfunction in children with fragile X syndrome

  2014cited by this paper
• IL-21 Is Required for Optimal Antibody Production and T Cell Responses during Chronic Toxoplasma gondii Infection

  2013cited by this paper
• Neonatal chemokine levels and risk of autism spectrum disorders: findings from a Danish historic birth cohort follow-up study.

  2013cited by this paper
• IL-27 acts on DCs to suppress the T cell response and autoimmunity by inducing expression of the immunoregulatory molecule CD39

  2013cited by this paper
• The Tolerogenic Peptide, hCDR1, Down-Regulates the Expression of Interferon-α in Murine and Human Systemic Lupus Erythematosus

  2013cited by this paper
• Diagnostic and Statistical Manual of Mental Disorders

  2013cited by this paper
• Elevated serum levels of macrophage-derived chemokine and thymus and activation-regulated chemokine in autistic children

  2013cited by this paper
• IL-21 optimizes T cell and humoral responses in the central nervous system during viral encephalitis

  2013cited by this paper
• The role of immune dysfunction in the pathophysiology of autism.

  2012cited by this paper
• Early behavioral intervention is associated with normalized brain activity in young children with autism.

  2012cited by this paper
• A validated regulatory network for Th17 cell specification.

  2012cited by this paper
• Cerebrospinal Fluid IL-21 Levels in Neuromyelitis Optica and Multiple Sclerosis

  2012cited by this paper
• Elevated serum levels of interleukin-17A in children with autism

  2012cited by this paper
• Plasma Cytokine Profiles in Subjects with High-Functioning Autism Spectrum Disorders

  2011cited by this paper
• Increased midgestational IFN-γ, IL-4 and IL-5 in women bearing a child with autism: A case-control study

  2011cited by this paper
• Maternal immune stimulation during pregnancy affects adaptive immunity in offspring to promote development of TH17 cells.

  2011cited by this paper
• IL-21 and IL-21 Receptor Expression in Lymphocytes and Neurons in Multiple Sclerosis Brain

  2011cited by this paper
• Elevated plasma cytokines in autism spectrum disorders provide evidence of immune dysfunction and are associated with impaired behavioral outcome.

  2011cited by this paper
• Critical role of IL-21 in modulating TH17 and regulatory T cells in Behçet disease.

  2011cited by this paper
• Recent advances in IL-22 biology.

  2011cited by this paper
• IL-17 and IL-22: siblings, not twins.

  2010cited by this paper
• Interleukin-21: a multifunctional regulator of immunity to infections.

  2010cited by this paper
• Contributions of the environment and environmentally vulnerable physiology to autism spectrum disorders

  2010cited by this paper
• Diverse targets of the transcription factor STAT3 contribute to T cell pathogenicity and homeostasis.

  2010cited by this paper
• Altered gene expression and function of peripheral blood natural killer cells in children with autism.

  2009cited by this paper
• Comparison of total protein concentration in skeletal muscle as measured by the Bradford and Lowry assays.

  2009cited by this paper
• CTLA-4 Control over Foxp3+ Regulatory T Cell Function

  2008cited by this paper
• Immune-based regulation of adult neurogenesis: implications for learning and memory.

  2008cited by this paper
• Diagnosing Autism Spectrum Disorders in Pre-school Children Using Two Standardised Assessment Instruments: The ADI-R and the ADOS

  2008cited by this paper
• Advances in autism genetics: on the threshold of a new neurobiology

  2008cited by this paper
• Decreased transforming growth factor beta1 in autism: a potential link between immune dysregulation and impairment in clinical behavioral outcomes.

  2008cited by this paper
• Interleukin 22 Is a Candidate Gene for Tmevp3, a Locus Controlling Theiler's Virus-Induced Neurological Diseases

  2007cited by this paper
• Suberosin inhibits proliferation of human peripheral blood mononuclear cells through the modulation of the transcription factors NF‐AT and NF‐κB

  2007cited by this paper
• Suppression of autoimmune inflammation of the central nervous system by interleukin 10 secreted by interleukin 27–stimulated T cells

  2007cited by this paper
• Human TH17 lymphocytes promote blood-brain barrier disruption and central nervous system inflammation

  2007cited by this paper
• Interleukin 27 limits autoimmune encephalomyelitis by suppressing the development of interleukin 17–producing T cells

  2006cited by this paper
• Interleukin (IL)-22 and IL-17 are coexpressed by Th17 cells and cooperatively enhance expression of antimicrobial peptides

  2006cited by this paper
• The immune response in autism: a new frontier for autism research

  2006cited by this paper
• Immunological findings in autism.

  2005cited by this paper
• Pro-inflammatory cytokines in autistic children in central Saudi Arabia.

  2005cited by this paper
• Astrocytes protect the CNS: antigen-specific T helper cell responses are inhibited by astrocyte-induced upregulation of CTLA-4 (CD152)

  2004cited by this paper
• Cytotoxic T lymphocyte antigen-4 (CTLA-4) limits the expansion of encephalitogenic T cells in experimental autoimmune encephalomyelitis (EAE)-resistant BALB/c mice

  2002cited by this paper
• Immunologic Self-Tolerance Maintained by Cd25+Cd4+Regulatory T Cells Constitutively Expressing Cytotoxic T Lymphocyte–Associated Antigen 4

  2000cited by this paper
• Autism Spectrum Disorders

  2000cited by this paper

• Genetic and epigenetic regulation of Treg cell fitness by autism-related chromatin remodeler CHD8

  2025cites this paper
• The Neuroimmunology of Autism

  2025cites this paper
• The Chromatin Remodeler Chd8 Regulates Hematopoietic Stem and Progenitor Cell Survival and Differentiation During Zebrafish Embryogenesis

  2025cites this paper
• Effect of vitamin D supplementation on inflammatory status and behavioral symptoms in children with autism spectrum disorders: a double-blind randomized clinical trial

  2025cites this paper
• Mast Cells in Autism Spectrum Disorder—The Enigma to Be Solved?

  2024cites this paper
• Neuroinflammation and autism: what have we learned so far?

  2024cites this paper
• Does the kynurenine pathway play a pathogenic role in autism spectrum disorder?

  2024cites this paper
• The association of maternal COVID-19-infection during pregnancy on the neonatal immune profile and associations with later diagnosis of neurodevelopmental disorders.

  2024cites this paper
• Human induced pluripotent stem cell-derived microglia contribute to the pathophysiology of Fragile X syndrome via increased RAC1 signaling

  2024cites this paper
• Evaluation of serum interleukin-17 A and interleukin-22 levels in pediatric patients with autism spectrum disorder: a pilot study

  2024cites this paper
• High-fat diet-induced obesity causes intestinal Th17/Treg imbalance that impairs the intestinal barrier and aggravates anxiety-like behavior in mice.

  2024cites this paper
• Upregulation of Inflammatory Mediators in Peripheral Blood CD40+ Cells in Children with Autism Spectrum Disorder

  2023influential citation
• Autistic spectrum disorder (ASD) – Gene, molecular and pathway signatures linking systemic inflammation, mitochondrial dysfunction, transsynaptic signalling, and neurodevelopment

  2023cites this paper
• Cadmium Exposure Is Associated with Behavioral Deficits and Neuroimmune Dysfunction in BTBR T+ Itpr3tf/J Mice

  2023cites this paper
• Aflatoxin B1 Exposure Aggravates Neurobehavioral Deficits and Immune Dysfunctions of Th1, Th9, Th17, Th22, and T Regulatory Cell-Related Transcription Factor Signaling in the BTBR T+Itpr3tf/J Mouse Model of Autism

  2023cites this paper
• Integrated microRNA–mRNA Expression Profiling Identifies Novel Targets and Networks Associated with Autism

  2022cites this paper
• Maternal Immune Activation and Interleukin 17A in the Pathogenesis of Autistic Spectrum Disorder and Why It Matters in the COVID-19 Era

  2022cites this paper
• Potential protein markers in children with Autistic Spectrum Disorder (ASD) revealed by salivary proteomics.

  2022cites this paper
• Re-emerging concepts of immune dysregulation in autism spectrum disorders

  2022cites this paper
• Chromatin remodeler CHD8 governs hematopoietic stem/progenitor survival by regulating ATM-mediated P53 protein stability.

  2021cites this paper
• Dysregulation of Ki-67 Expression in T Cells of Children with Autism Spectrum Disorder

  2021cites this paper
• Vitamin D and Autism Spectrum Disorder

  2021cites this paper
• Autism and IL-17 & IL-18

  2021cites this paper
• Systems Pharmacology Approach and Experiment Evaluation Reveal Multidimensional Treatment Strategy of LiangXueJieDu Formula for Psoriasis

  2021cites this paper
• Increased IL-17 and IL-21 Receptor Levels in Children with Autism

  2021cites this paper
• 3-Aminobenzamide alleviates elevated DNA damage and DNA methylation in a BTBR T+Itpr3tf/J mouse model of autism by enhancing repair gene expression.

  2020cites this paper
• Oxidative Stress in Autism Spectrum Disorder

  2020cites this paper
• A perinatal strategy to prevent autism

  2020cites this paper
• C-C motif chemokine receptor 6-mediated pro-inflammatory mediator expression is associated with immune dysfunction in children with autism

  2020cites this paper
• Involvement of CD45 cells in the development of autism spectrum disorder through dysregulation of granulocyte-macrophage colony-stimulating factor, key inflammatory cytokines, and transcription factors.

  2020cites this paper
• Astronium fraxinifolium Schott Exerts Leishmanicidal Activity by Providing a Classically Polarized Profile in Infected Macrophages

  2020cites this paper
• Vorinostat is genotoxic and epigenotoxic in the mouse bone marrow cells at the human equivalent doses.

  2020cites this paper
• Inflammation and Mitochondrial Dysfunction in Autism Spectrum Disorder.

  2020cites this paper
• Upregulation of interleukin (IL)-31, a cytokine producing CXCR1 peripheral immune cells, contributes to the immune abnormalities of autism spectrum disorder.

  2020cites this paper
• Immune regulation of neurodevelopment at the mother–foetus interface: the case of autism

  2020cites this paper
• The Stat3 inhibitor, S3I-201, downregulates lymphocyte activation markers, chemokine receptors, and inflammatory cytokines in the BTBR T+ Itpr3tf/J mouse model of autism.

  2019cites this paper
• Dysregulation of T cell immunoglobulin and mucin domain 3 (TIM-3) signaling in peripheral immune cells is associated with immune dysfunction in autistic children.

  2019cites this paper
• Microbiota and gut-brain axis dysfunction in autism spectrum disorder: Evidence for functional gastrointestinal disorders.

  2019cites this paper
• Inhibition of tyrosine kinase signaling by tyrphostin AG126 downregulates the IL-21/IL-21R and JAK/STAT pathway in the BTBR mouse model of autism.

  2019cites this paper
• The histamine-4 receptor antagonist JNJ7777120 prevents immune abnormalities by inhibiting RORγt/T-bet transcription factor signaling pathways in BTBR T+ Itpr3tf/J mice exposed to gamma rays.

  2019cites this paper
• Resveratrol Improves Neuroimmune Dysregulation Through the Inhibition of Neuronal Toll-Like Receptors and COX-2 Signaling in BTBR T+ Itpr3tf/J Mice

  2018cites this paper
• Upregulation of peripheral CXC and CC chemokine receptor expression on CD4+ T cells is associated with immune dysregulation in children with autism

  2018influential citation
• Downregulation in Helios transcription factor signaling is associated with immune dysfunction in blood leukocytes of autistic children

  2018cites this paper
• Neuroimmunologic and Neurotrophic Interactions in Autism Spectrum Disorders: Relationship to Neuroinflammation

  2018cites this paper
• Resveratrol attenuates pro‐inflammatory cytokines and activation of JAK1‐STAT3 in BTBR T+ Itpr3tf/J autistic mice

  2018cites this paper
• Immune Abnormalities in Autism Spectrum Disorder—Could They Hold Promise for Causative Treatment?

  2018cites this paper
• Elevated IL-16 expression is associated with development of immune dysfunction in children with autism

  2018cites this paper
• Immune Dysfunction and Autoimmunity as Pathological Mechanisms in Autism Spectrum Disorders

  2018cites this paper
• Dysregulation of the expression of HLA‐DR, costimulatory molecule, and chemokine receptors on immune cells in children with autism

  2018cites this paper
• S3I-201, a selective Stat3 inhibitor, restores neuroimmune function through upregulation of Treg signaling in autistic BTBR T+ Itpr3tf/J mice.

  2018cites this paper
• Immunological Dysfunction in Autism Spectrum Disorder: A Potential Target for Therapy

  2018cites this paper
• Protection by tyrosine kinase inhibitor, tyrphostin AG126, through the suppression of IL-17A, RORγt, and T-bet signaling, in the BTBR mouse model of autism.

  2018cites this paper
• Toll-like receptors, NF-κB, and IL-27 mediate adenosine A2A receptor signaling in BTBR T+ Itpr3tf/J mice.

  2017cites this paper
• Upregulation of IL-9 and JAK-STAT signaling pathway in children with autism.

  2017cites this paper
• Adenosine A2A receptor signaling affects IL-21/IL-22 cytokines and GATA3/T-bet transcription factor expression in CD4+ T cells from a BTBR T+ Itpr3tf/J mouse model of autism.

  2017cites this paper
• Activation of adenosine A2A receptor signaling regulates the expression of cytokines associated with immunologic dysfunction in BTBR T+ Itpr3tf/J mice

  2017cites this paper